Effect of intensive LDL cholesterol lowering with PCSK9 monoclonal antibodies on tendon xanthoma regression in familial hypercholesterolemia.

A. Bea,S. Pérez-Calahorra,V. Marco-Benedí,I. Lamiquiz-Moneo,E. Jarauta,R. Mateo-Gallego,F. Civeira
DOI: https://doi.org/10.1016/j.atherosclerosis.2017.06.009
IF: 5.3
2017-08-01
Atherosclerosis
Abstract:
What problem does this paper attempt to address?